¡æ Tissue microarray technology, which
was first used in published research by J. Kononen et al.
(Nature Medicine Vol 4. No. 7, 1998
pp. 844-847), has been drawing
a great deal of attention recently from a wide variety of research
interests. The technology itself is very similar to other high throughput
systems such as DNA microarray, protein array etc. from several ways(Please,
see the ¡°Tissue
Microarray¡± on this website).
The
technology enhances the productivity of drug development by shortening
target validation and allowing to check the cross reactivity of
a therapeutic antibody candidate in a very short period of time.
In addition to these commercial advantages, many academic researchers
can enhance their research performance in the various fields of
basic life science,
especially medical science.
1) American Journal of Pathology
2001 158: 1335-1344. Expression and Potential Role
of Fas-Associated Phosphatase-1 in Ovarian Cancer
Ivo Meinhold-Heerlein, Frank Stenner-Liewen, Heike Liewen, Shinichi
Kitada, Maryla Krajewska, Stanislaw Krajewski, Juan M. Zapata, Anne
Monks, Dominic A. Scudiero, Thomas Bauknecht, and John C. Reed
2) The American Journal of Surgical Pathology 2002
26:312-319 Tissue Microarray Sampling Strategy
for Prostate Cancer Biomarker Analysis
Mark A. Rubin, M.D.; Rodney Dunn, M.S.; Myla Strawderman, M.S.; Kenneth
J. Pienta, M.D.
3)
Cancer Research 2002 62: 1256-1260. Clinical Validation
of Candidate Genes Associated with Prostate Cancer Progression in
the CWR22 Model System using Tissue Microarrays
Spyro Mousses, Lukas Bubendorf, Urs Wagner, Galen Hostetter, Juha
Kononen, Robert Cornelison, Natalie Goldberger, Abdel G. Elkahloun,
Niels Willi, Pasi Koivisto, William Ferhle, Mark Raffeld, Guito Sauter,
and Olli-P Kallioniemi
4)
Cancer Research 1999 59: 803-806. High-Throughput
Tissue Microarray Analysis of 3p25 (RAF1) and 8p12 (FGFR1) Copy Number
Alterations in Urinary Bladder Cancer
Ronald Simon, Jan Richter, Urs Wagner, Andre Fijan, James Bruderer,
Ulrico Schmid, Daniel Ackermann, Robert Maurer, Goran Alund, Hartmut
Knonagel, Marcus Rist, Kim Wilber, Manuel Anabitarte, Franz Hering,
Thomas Hardmeier, Andreas Schonenberger, Renata Flury, Peter Jager,
Jean Luc Fehr, Peter Schraml, Holger Moch, Michael J. Mihatsch, Thomas
Gasser, and Guido Sauter
5)
Cancer Research 2001 61: 4514-4519. High-Throughput
Tissue Microarray Analysis of Cyclin E Gene Amplification and Overexpression
in Urinary Bladder Cancer
Jan Richter, Urs Wagner, Juha Kononen, Andre Fijan, James Bruderer,
Ulrico Schmid, Daniel Ackermann, Robert Maurer, Goran Alund, Hartmut
Knonagel, Marcus Rist, Kim Wilber, Manuel Anabitarte, Franz Hering,
Thomas Hardmeier, Andreas Schonenberger, Renata Flury, Peter Jager,
Jean Luc Fehr, Peter Schraml, Holger Moch, Michael J. Mihatsch, Thomas
Gasser, Olli P. Kallioniemi, and Guido Sauter
6)
The Journal of Pathology 2001 194 (3): 349-357 Microarrays
of bladder cancer tissue are highly representative of proliferation
index and histological grade
Antonio Nocito, Lukas Bubendorf, Eva Maria Tinner, Katrin Suess, Urs
Wagner, Thomas Forster, Juha Kononen, Andre Fijan, James Bruderer,
Ulrico Schmid, Daniel Ackermann, Robert Maurer, Goran Alund, Hartmut
Knonagel, Marcus Rist, Manuel Anabitarte, Franz Hering, Thomas Hardmeier,
Andreas J. Schoenenberger, Renata Flury, Peter Jager, Jean Luc Fehr,
Peter Schraml, Holger Moch, Michael J. Mihatsch, Thomas Gasser, Guido
Sauter
7) American
Journal of Pathology 1999 154: 981-986. Identification
of Differentially Expressed Genes in Human Gliomas by DNA Microarray
and Tissue Chip Techniques
Satu-Leena Sallinen, Pauli K. Sallinen, Hannu K. Haapasalo, Heikki
J. Helin, Pauli T. Helen, Peter Schraml, Olli-P. Kallioniemi, and
Juha Kononen
8) Applied
Immunohistochemistry & Molecular Morphology 2001 9:358-363 Tissue Microarray Analysis of ß-Catenin in Colorectal Cancer
Shows Nuclear Phospho-ß-catenin Is Associated with a Better Prognosis
Gina G. Chung, Elayne Provost, Eric P. Kielhorn, Lori A. Charette,
Bradley L. Smith, and David L. Rimm
9)
Clinical Cancer Research 2001 7: 4013-4020. Clinical
Significance of Molecular Expression Profiles of Hurthle Cell Tumors
of the Thyroid Gland Analyzed via Tissue Microarrays
Axel Hoos, Alexander Stojadinovic, Bhuvanesh Singh, Maria E. Dudas,
Denis H. Y. Leung, Ashok R. Shaha, Jatin P. Shah, Murray F. Brennan,
Carlos Cordon-Cardo, and Ronald Ghossein
10)
American Journal of Pathology 2002 160: 175-183. Reduction
of Hematopoietic Cell-Specific Tyrosine Phosphatase SHP-1 Gene Expression
in Natural Killer Cell Lymphoma and Various Types of Lymphomas/Leukemias
: Combination Analysis with cDNA Expression Array and Tissue Microarray
